EUVIMEDEUVIMED entdecken
Crossref

Ebola outbreak puts nimble treatment trial designs to the test

Kai Kupferschmidt

Science · 28.05.2026 · 392 (6801) · 910-911

DOI: 10.1126/science.aej2010 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science, erschienen am 28.05.2026. Verfasst von Kai Kupferschmidt. Hauptthemen laut MEDLINE: Antiviral Agents, Disease Outbreaks, Hemorrhagic Fever, Ebola, Therapies, Investigational.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Updated strategies for studying antivirals and antibodies will face logistical challenges on the ground

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiviral AgentsDisease OutbreaksHemorrhagic Fever, EbolaTherapies, InvestigationalHumansAntibodies, ViralEbolavirusAdenosine MonophosphateAlanine

Substanzen

Antibodies, ViralAntiviral AgentsremdesivirAdenosine MonophosphateAlanine

Zitieren

APA

Kupferschmidt, K. (2026). Ebola outbreak puts nimble treatment trial designs to the test. Science, 392(6801), 910-911. https://doi.org/10.1126/science.aej2010

Vancouver

Kupferschmidt K. Ebola outbreak puts nimble treatment trial designs to the test. Science. 2026;392(6801):910-911. doi:10.1126/science.aej2010

BibTeX
@article{Kupferschmidt2026,
  author = {Kupferschmidt, Kai},
  title = {Ebola outbreak puts nimble treatment trial designs to the test},
  journal = {Science},
  year = {2026},
  volume = {392},
  number = {6801},
  pages = {910--911},
  doi = {10.1126/science.aej2010}
}
Kostenlos starten →